Citius Pharmaceuticals, Inc.
CTXR
$1.32
$0.064.76%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22,964.77% | -97.60% | -66.17% | -81.84% | 42.61% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 12.19% | 6.66% | 73.92% | -- | -- |
| Prepaid Expenses | -56.35% | 5.73% | 5.40% | -73.25% | 11.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 33.94% | 0.26% | 28.88% | -49.22% | 29.81% |
|
|
|||||
| Total Current Assets | 33.94% | 0.26% | 28.88% | -49.22% | 29.81% |
| Net Property, Plant & Equipment | -4.49% | 381.77% | -22.26% | -17.91% | -14.99% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 56.23% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 5.10% | 0.64% | 3.47% | 20.15% | 7.03% |
|
|
|||||
| Total Accounts Payable | 7.75% | 27.21% | 49.46% | 196.23% | -37.69% |
| Total Accrued Expenses | 2.26% | 35.37% | 293.47% | -0.32% | 76.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -20.95% | -29.08% | -15.28% | 2.50% | 2.57% |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Other Current Liabilities | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Current Liabilities | 3.94% | 11.32% | 25.10% | 762.57% | -0.51% |
|
|
|||||
| Total Current Liabilities | 3.94% | 11.32% | 25.10% | 762.57% | -0.51% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.50% | -- | -- | -74.76% | -41.83% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.65% | 3.79% | 3.94% | 2.19% | 2.24% |
| Total Liabilities | 3.82% | 11.82% | 21.70% | 293.75% | 0.58% |
|
|
|||||
| Common Stock & APIC | 4.67% | 2.23% | 1.88% | -1.74% | 6.51% |
| Retained Earnings | -3.96% | -5.17% | -4.85% | -5.66% | -5.87% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 7.25% | -7.26% | -6.66% | -18.21% | 7.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.25% | -7.26% | -6.66% | -18.21% | 7.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -14.20% | -16.94% | -12.75% | 570.29% | 0.00% |
| Total Equity | 6.27% | -7.75% | -6.99% | -14.12% | 7.90% |
|
|
|||||